Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma.

BMC Med · 2026 · PMC12994253 · PMID 41840689

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Many studies have used xenograft models of osteosarcoma, but a novel aggressive PDX model would be a highly significant tool to test new therapeutics.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.